Tianeptine and alcohol dependence

European Neuropsychopharmacology

Volumn 7, Issue SUPPL. 3, 1997, Pages

  Favre, J D ^a   Guelfi Sozzi, C ^b   Delalleau, B ^b   Loo H ^c  

^a PERCY MILITARY HOSPITAL   (France)

^b IRIS Institut de Recherches Internationales Servier   (France)

^c CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

Alcohol dependence; Alcoholic relapse; Depression; Placebo; Tianeptine

Indexed keywords

PLACEBO; TIANEPTINE;

ADULT; ALCOHOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ALCOHOLISM; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; THIAZEPINES; TIME FACTORS;

EID: 0030714074     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(97)00068-0     Document Type: Conference Paper

References (30)

1. American Psychiatric Association, 1987. Diagnostic and Statistical Manual of Mental Disorders, third ed. revised. American Psychiatric Association, Washington.
2. American Psychiatric Association, 1995. Practice guideline for the treatment of patients with substance use disorders: alcohol, cocaine, opioids. American Psychiatric Association, Washington, p. 152 (11 Suppl.).
3. Aubin H.J., Barrucand D. Les médicaments sérotoninergiques dans le traitement de l'appétence à l'alcool. Alcoologie. 15(3):1993;169-174.
4. Bobon, D., 1981. Le système AMDP, Deuxième édition. Mardaga, Bruxelles.
5. Daoust M., Compagnon P., Legrand E., Mocaer E. Tianeptine, a specific serotonin uptake enhancer, decreases ethanol intake in rats. Alcohol Alcohol. 27(1):1992;15-17.
6. Delalleau B., Dulcire C., Le Moine P., Kamoun A. Analysis of the side-effects of tianeptine. Clin. Neuropharmacol. 11(Suppl. 2):1988;83-89.
7. Derogatis C.R., Lipman R.S., Rickels K.et al. The Hopkins Symptom Check-List (HSCL): a self-report symptom inventory. Behav. Sci. 19:1974;1-15.
8. Donovan, D.M., Mattson, M.E., 1994. Alcoholism treatment matching research: methodological and clinical issues. J. Stud. Alcohol 12 (Suppl.), 5-15.
9. Favre, J.D., Gillet, C., Jean, P., 1991. Premières conclusions d'une recherche sur l'évaluation des soins donnés aux malades alcooliques. In: Chanoit, P.F., de Verbizier, J. (Eds). Psychiatrie Sociale à l'heure Européenne. Érès, Toulouse, pp. 363-373.
10. Favre J.D., Lôo H., Marey C., Delalleau B. Long-term efficacy of tianeptine on alcoholic relapses in non-depressed alcoholic patients. Preliminary results. Eur. Psychiatry. 8(Suppl. 2):1993;125-129.
11. Finney J.W., Moos R.H. The long term course of treated alcoholism: II. Predictors and correlates of 10-year functioning and mortality. J. Stud. Alcohol. 53(2):1992;142-153.
12. Fuller R.K., Branchey L., Brightwell D.R.et al. Disulfiram treatment of alcoholism. A veterans administration cooperative study. J. Am. Med. Assoc. 256(11):1986;1449-1455.
13. Guelfi J.D., Pichot P., Dreyfus J.F. Efficacy of tianeptine in anxious-depressed patients: results of a controlled multicenter trial versus amitriptyline. Neuropsychobiology. 22:1989;41-48.
14. The Plinius Maior Society, 1994. Guidelines on evaluation of treatment of alcohol dependence. Alcoholism 30 (Suppl.), 1-86.
15. Guy, W., Ban, M., 1982. ADMP system. Springer-Verlag, Berlin.
16. Guy, W., 1976. ECDEU Assessment Manual for Psychopharmacology. US Department of Health Education and Welfare, Washington.
17. Invernizzi G., Aguglia E., Bertolino A.et al. The efficacy and safety of tianeptine in the treatment of depressive disorder: results of a controlled double-blind multicentre study versus amitriptyline. Neuropsychobiology. 30:1994;85-93.
18. LeMarquand D., Pihl R.O., Benkelfat C. Serotonin and alcohol intake, abuse, dependence: clinical evidence. Biol. Psychiatry. 36:1994;326-337.
19. Lôo H., Zarifian E., Kamoun A. Place de la tianeptine parmi les antidépresseurs. Biol. Psychiatry. 5:1981;609-612.
20. Lôo H., Deniker P. Position of tianeptine among antidepressive chemotherapies. Clin. Neuropharmacol. 11(Suppl. 2):1988;S97-S102.
21. Lôo H., Malka R., Defrance R.et al. Tianeptine and amitriptyline: controlled double-blind trial in depressed alcoholic patients. Neuropsychobiology. 19:1988;79-85.
22. Malka R., Lôo H., Ganry H., Souche A., Marey C., Kamoun A. Long-term administration of tianeptine in depressed patients after alcohol withdrawal. Br. J. Psychiatry. 160(Suppl. 15):1992;66-71.
23. Miller N.S. Psychiatric comorbidity. Occurrence and treatment. Alcohol Health Res. World. 18(4):1994;261-264.
24. Montgomery S.A., Åsberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry. 134:1979;382-389.
25. Ollat H. Alcool et dépression. Alcoologie. 14(3-4):1992;135-147.
26. Ostaptzeff G. Étude contrôlée à double insu versus imipramine de l'efficacité de la tianeptine dans des états dépressifs non psychotiques. Biol. Psychiatry. 5:1981;597-600.
27. Paykel E.S. Methodological aspects of life events research. J. Psychosom. Res. 27(5):1983;341-352.
28. Schuckit M.A. Genetic and clinical implications of alcoholism and affective disorders. Am. J. Psychiatry. 143:1986;140-147.
29. Selzer M.L., Vinokur A., Van Rooijen L. A self-administered Short Michigan Alcoholism Screening Test (S Mast). J. Stud. Alcohol. 36:1975;117-126.
30. Tarter R.E., Alterman A.I., Edwars K.L. Vulnerability to alcoholism in men: a behavior-genetic perspective. J. Stud. Alcohol. 46:1985;329-356.